SEC Form 4 research
| Issuer | Krystal Biotech, Inc. |
|---|---|
| Tickers | KRYS |
| Reporting owners | 18 |
| Officers and directors | 7 |
| Last public filing | 2026-09-17 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-16 | 2026-09-14 | ROSSI DINO A | A | 471 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | ROSSI DINO A | A | 1,187 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | Sutherland Everett Rand | A | 471 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | Sutherland Everett Rand | A | 1,187 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | Mazzacco Catherine | A | 471 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | Mazzacco Catherine | A | 1,187 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | Mason Christopher | A | 471 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | Mason Christopher | A | 1,187 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | JANNEY DANIEL | A | 471 | $0 | Not reported |
| 2026-09-16 | 2026-09-14 | JANNEY DANIEL | A | 1,187 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.